19736 S0453 M1 1571

Document text

BioNTech SE 08/14/2021
An der Goldgrube 12
Mainz Rhineland-Palatinate
Germany 55131(212) 733-2613
COVID-19 Vaccine (BNT162, PF-07302048) 019736
Prophylactic immunization against COVID-19 in adults 
16 years of age
0 4 5 2
3
FDA-CBER-2021 5683-1112216
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE
Özlem Türeci, MD, Chief Medical Officer, BioNTech SE 
Neda Aghajani Memar, Director, Pfizer Global Regulatory Affairs - Vaccines
(212) 733-2613 (845) 474-3500 
235 East 42nd Street 
 
New York NY
United States of America [email protected] 
08/14/2021
United States of America
3
(b) (6)
FDA-CBER-2021-5683-1112217
3
FDA-CBER-2021-5683-1112218